Your browser doesn't support javascript.
loading
Immunotherapy using IgE or CAR T cells for cancers expressing the tumor antigen SLC3A2.
Pellizzari, Giulia; Martinez, Olivier; Crescioli, Silvia; Page, Robert; Di Meo, Ashley; Mele, Silvia; Chiaruttini, Giulia; Hoinka, Jan; Batruch, Ihor; Prassas, Ioannis; Grandits, Melanie; López-Abente, Jacobo; Bugallo-Blanco, Eva; Ward, Malcolm; Bax, Heather J; French, Elise; Cheung, Anthony; Lombardi, Sara; Figini, Mariangela; Lacy, Katie E; Diamandis, Eleftherios P; Josephs, Debra H; Spicer, James; Papa, Sophie; Karagiannis, Sophia N.
Afiliação
  • Pellizzari G; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Martinez O; Immunoengineering Group, King's College London, London, England, UK.
  • Crescioli S; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Page R; Immunoengineering Group, King's College London, London, England, UK.
  • Di Meo A; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Mele S; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Chiaruttini G; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Hoinka J; Computational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland, USA.
  • Batruch I; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Prassas I; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Grandits M; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • López-Abente J; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Bugallo-Blanco E; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Ward M; Immunoengineering Group, King's College London, London, England, UK.
  • Bax HJ; Aulesa Biosciences Ltd, Shefford, England, UK.
  • French E; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Cheung A; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Lombardi S; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Figini M; Breast Cancer Now Research Unit, School of Cancer and Pharmaceutical Sciences, King's College London, London, England, UK.
  • Lacy KE; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Diamandis EP; School of Cancer and Pharmaceutical Sciences, King's College London, London, England, UK.
  • Josephs DH; Biomarker Unit, Dipartimento di Ricerca Applicata e Sviluppo Tecnologico (DRAST), Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Spicer J; St John's Institute of Dermatology, School of Basic and Medical Biosciences, King's College London, London, England, UK.
  • Papa S; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Karagiannis SN; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
J Immunother Cancer ; 9(6)2021 06.
Article em En | MEDLINE | ID: mdl-34112739

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Cadeia Pesada da Proteína-1 Reguladora de Fusão / Receptores de Antígenos Quiméricos / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoglobulina E / Cadeia Pesada da Proteína-1 Reguladora de Fusão / Receptores de Antígenos Quiméricos / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido